EP2880448
HUMAN PAPILLOMA VIRUS AS PREDICTOR OF CANCER PROGNOSIS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.8.2013EP published:
29.6.2022EP application number:
13825462.8
EPO information:
European Patent Register
Max expiry date:
1.8.2033
Title in English:
HUMAN PAPILLOMA VIRUS AS PREDICTOR OF CANCER PROGNOSISLanguage of the patent:
English
Timeline
Today
2.8.2013EP application
29.6.2022EP Publication
Owner
Name:
Foundation Medicine, Inc.Address:
150 Second Street, Cambridge, MA 02141, US
Name:
UCL Business LtdAddress:
University College London Gower Street, London WC1E 6BT, GB
Inventor
Name:
YELENSKY, RomanAddress:
Newton, MA 02460, US
Name:
BOSHOFF, Chris, HendrikAddress:
London W1G 8RN, GB
Name:
FENTON, Timothy, RobertAddress:
Rochester Kent ME2 4GX, GB
Name:
LECHNER, Matthias, AlexanderAddress:
London SW1A 2BX, GB
Name:
STEPHENS, Philip, JamesAddress:
Lexington, MA 02421, US
Name:
HAWRYLUK, Matthew, J.Address:
Watertown, MA 02472, US
Name:
FRAMPTON, Garrett, MichaelAddress:
Somerville, MA 02144, US
Priority
Number:
201261679354 PDate:
3.8.2012Country:
US
Classification
Categories:
A61K 31/404, G01N 33/574, A61K 31/436, A61K 31/05, A61K 31/282, A61K 31/337, A61K 31/336, A61K 31/4196, A61K 31/454, A61K 31/4709, A61K 31/4745, A61K 31/496, A61K 31/505, A61K 31/506, C12Q 1/6886, C12Q 1/70